Elsayad Khaled, Kriz Jan, Seegenschmiedt Heinrich, Imhoff Detlef, Heyd Reinhard, Eich Hans Theodor, Micke Oliver
Department of Radiotherapy and Radiation Oncology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building A1, 48149, Muenster, Germany.
Radiotherapy Center Hamburg, Hamburg, Germany.
Strahlenther Onkol. 2017 Apr;193(4):332-340. doi: 10.1007/s00066-016-1085-6. Epub 2016 Dec 12.
Aneurysmal bone cysts (ABC) are rapidly growing benign osseous lesions composed of blood-filled channels separated by fibrous septa. Since the value of external beam radiotherapy (EBRT) for ABC has not been well defined, the German Cooperative Group on Radiotherapy for Benign Diseases performed the national register study described herein.
Five German institutions collected data regarding clinical features, treatment concepts, and outcome for patients with ABC who had been referred for local EBRT over the past 30 years.
Between 1990 and 2015, 10 patients with ABC were irradiated (5 female/5 male). Median age was 23 years (range 14-40 years). Involved sites were: spine (n = 3), sacrum/pelvis (n = 2), shoulder/scapula (n = 2), humerus (n = 1), femur (n = 1), and radius (n = 1). The median EBRT total and fractional doses were 28 Gy (range 5-40 Gy) and 2 Gy (range 1-2 Gy), respectively. Median follow-up was 65 months (range 12-358 months). Persistent pain relief was achieved for all patients. However, long-term follow-up response data were only available for 7/10 patients. All 7 patients exhibited a radiological response and experienced no recurrent disease activity or pain during follow-up. Acute and late radiogenic toxicities ≥ grade 3 and secondary malignancies were also not observed.
Primary or adjuvant EBRT seems to be an effective and safe treatment option for persistent or recurrent ABC. Fractionated doses below 30 Gy may be recommended.
骨动脉瘤样囊肿(ABC)是一种快速生长的良性骨病变,由纤维间隔分隔的充满血液的通道组成。由于外照射放疗(EBRT)对ABC的价值尚未明确界定,德国良性疾病放疗合作组开展了本文所述的全国登记研究。
五家德国机构收集了过去30年因局部EBRT转诊的ABC患者的临床特征、治疗方案及治疗结果数据。
1990年至2015年期间,10例ABC患者接受了放疗(5例女性/5例男性)。中位年龄为23岁(范围14 - 40岁)。受累部位包括:脊柱(n = 3)、骶骨/骨盆(n = 2)、肩部/肩胛骨(n = 2)、肱骨(n = 1)、股骨(n = 1)和桡骨(n = 1)。EBRT的中位总剂量和分次剂量分别为28 Gy(范围5 - 40 Gy)和2 Gy(范围1 - 2 Gy)。中位随访时间为65个月(范围12 - 358个月)。所有患者均实现了持续的疼痛缓解。然而,仅7/10的患者有长期随访反应数据。所有7例患者均表现出放射学反应,且在随访期间未出现疾病复发活动或疼痛。也未观察到≥3级的急性和晚期放射毒性及继发性恶性肿瘤。
对于持续性或复发性ABC,原发性或辅助性EBRT似乎是一种有效且安全的治疗选择。建议分次剂量低于30 Gy。